A survey conducted in the early months of the pandemic revealed cancer survivors’ greatest concerns regarding their care, prognosis, and finances.
A team of researchers conducted a study to assess the impact of the COVID-19 pandemic on the initiation of clinical trials in oncology.
As COVID-19 vaccine rollout continues, the NCCN released its preliminary recommendations regarding vaccination administration to patients with cancer.
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.